To explore how c-MYC mediates resistance to T/CQ, we examined the cell division cycle, one of the hallmarks of cancer modulated by activated KRAS and c-MYC (Gysin et al., 2005; Gysin et al., 2012; Hanahan and Weinberg, 2000). Here, KRAS is linked to cancer.